Interestingly, among patients with FABP4 expression at the tumor border, 32.6% (15 out of 46 cases) exhibited tumor lymphovascular invasion, a significantly higher rate than the 14% (7 out of 50 cases) observed in patients without FABP4 expression at the tumor border (Fig. 4J). The gene discussed is FABP4; the disease is neoplasm.